Hungarian-Developed COVID-19 Drug Shows Promise After Tests

2021. január 26.

Budapest Business Journal

A drug developed by a consortium of Hungarian researchers, including ones from Budapest's Eötvös Loránd University (ELTE) and pharmaceutical company Gedeon Richter, appears to be effective for the treatment of coronavirus based on animal tests, ELTE immunologist Imre Kacskovics, who heads the researchers, said on public radio on Tuesday, according to a report by Hungarian news agency MTI.